Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Engineering cancer avatars with microfluidics, biofabrication and biosensors.

Biofabrication·2026

Same author

3D bioprinting meets nanotherapeutics: a vehicle for sustained extracellular vesicle delivery.

Biomaterials·2025

Same author

Engineered ratiometric Sensory electrospun fibers for oxygen mapping in complex cultures and tumor microenvironment.

Biosensors & bioelectronics·2025

Same author

Patterned glycopeptide-based supramolecular hydrogel promotes the alignment and contractility of iPSC-derived cardiomyocytes.

Biomaterials advances·2024

Same author

Biomimetic and soft lab-on-a-chip platform based on enzymatic-crosslinked silk fibroin hydrogel for 3D cell co-culture.

Biomedical materials (Bristol, England)·2024

Same author

Human Tendon-on-Chip: Unveiling the Effect of Core Compartment-T Cell Spatiotemporal Crosstalk at the Onset of Tendon Inflammation.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2024

Search research articles

Related Experiment Video

Updated: Sep 6, 2025

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Published on: October 13, 2023

Emerging Microfluidic and Biosensor Technologies for Improved Cancer Theranostics.

David Caballero^1,2, Catarina M Abreu^3,4, Rui L Reis^3,4

¹3B's Research Group, I3Bs - Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Barco, Guimarães, Portugal. dcaballero@i3bs.uminho.pt.

Advances in Experimental Medicine and Biology

|June 27, 2022

Summary

This summary is machine-generated.

Microfluidics and biosensors offer advanced tools for cancer research, improving diagnosis and therapy. These technologies enhance point-of-care devices and cancer theranostics, despite facing adoption challenges.

Keywords:

Biosensors Cancer diagnosis Cancer therapeutics Microfluidics Personalized medicine Point-of-care

More Related Videos

Microfluidic Platform with Multiplexed Electronic Detection for Spatial Tracking of Particles

Microfluidic Platform with Multiplexed Electronic Detection for Spatial Tracking of Particles

Published on: March 13, 2017

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

Related Experiment Videos

Last Updated: Sep 6, 2025

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Published on: October 13, 2023

Microfluidic Platform with Multiplexed Electronic Detection for Spatial Tracking of Particles

Microfluidic Platform with Multiplexed Electronic Detection for Spatial Tracking of Particles

Published on: March 13, 2017

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

Area of Science:

Biomedical Engineering
Oncology
Analytical Chemistry

Background:

Microfluidics and biosensors are valuable in cancer research for modeling tumor microenvironments and monitoring drug efficacy.
Point-of-care biosensing platforms are crucial for early biomarker detection and quantification.
Combining microfluidics and biosensors presents significant advantages for cancer management and patient prognosis.

Purpose of the Study:

To discuss emerging microfluidic and biosensor technologies for enhancing cancer theranostics.
To explore how these tools can improve the predictive power of point-of-care devices.
To highlight advancements in cancer diagnosis and therapy development.

Main Methods:

Review of innovative microfluidic devices for tumor microenvironment modeling.
Analysis of biosensing platforms for biomarker detection and drug efficacy screening.
Integration of microfluidics and biosensors for improved cancer theranostic applications.

Main Results:

Emerging technologies show potential to overcome current limitations in standardization and reproducibility.
Combined approaches enhance the efficiency of cancer diagnosis and treatment monitoring.
Unconventional tools are being developed to boost the predictive power of point-of-care diagnostics.

Conclusions:

Microfluidics and biosensors are critical for advancing cancer theranostics.
Addressing technical complexity and standardization is key for market adoption.
These integrated technologies promise to significantly improve patient outcomes in cancer care.